Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

SHE:300832 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	45,022	55,668	61,443	39,416	34,652	54,455
Market Cap Growth	-11.97%	-9.40%	55.88%	13.75%	-36.36%	-
Enterprise Value	42,547	53,087	58,196	36,274	31,451	51,757
Last Close Price	57.30	69.27	75.46	47.80	41.41	64.81
PE Ratio	24.47	30.45	37.16	29.68	35.59	57.98
Forward PE	22.86	25.23	31.02	27.83	28.70	47.78
PS Ratio	9.71	12.27	15.64	12.94	13.61	24.81
PB Ratio	5.00	6.49	8.14	6.16	6.18	11.34
P/TBV Ratio	5.14	6.68	8.33	6.33	6.28	11.57
P/FCF Ratio	59.75	60.69	56.06	70.49	80.54	75.44
P/OCF Ratio	40.44	41.04	43.32	40.96	44.82	55.76
EV/Sales Ratio	9.17	11.71	14.81	11.91	12.36	23.58
EV/EBITDA Ratio	20.09	25.17	30.83	25.11	27.32	46.98
EV/EBIT Ratio	22.06	27.49	33.49	27.22	29.74	50.61
EV/FCF Ratio	56.47	57.88	53.09	64.87	73.10	71.70
Debt / Equity Ratio	0	0	0.00	0	0	-
Debt / EBITDA Ratio	0.00	0.00	0.00	0.00	0.00	-
Debt / FCF Ratio	0.01	0.00	0.01	0.00	0.01	-
Asset Turnover	0.51	0.51	0.52	0.46	0.45	0.50
Inventory Turnover	1.31	1.20	1.21	1.22	1.33	1.44
Quick Ratio	6.02	4.13	6.96	6.73	7.31	7.30
Current Ratio	8.42	5.56	8.56	8.26	8.85	8.37
Return on Equity (ROE)	21.68%	22.68%	23.72%	22.11%	18.70%	23.65%
Return on Assets (ROA)	13.17%	13.53%	14.26%	12.67%	11.55%	14.59%
Return on Capital (ROIC)	14.20%	14.97%	15.57%	13.87%	12.69%	16.09%
Return on Capital Employed (ROCE)	21.10%	22.20%	22.80%	20.70%	18.80%	21.20%
Earnings Yield	4.09%	3.28%	2.69%	3.37%	2.81%	1.73%
FCF Yield	1.67%	1.65%	1.78%	1.42%	1.24%	1.33%
Dividend Yield	2.24%	1.88%	1.32%	1.47%	1.45%	2.03%
Payout Ratio	42.74%	42.98%	33.15%	35.53%	42.46%	65.91%
Buyback Yield / Dilution	-0.00%	0.01%	0.07%	-0.04%	-4.76%	-6.61%
Total Shareholder Return	2.26%	1.89%	1.39%	1.42%	-3.31%	-4.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.